<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="rapid-communication" dtd-version="1.1" specific-use="sps-1.9" xml:lang="pt">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id specific-use="scielo-v3" pub-id-type="publisher-id">qqkKmwpkkRfwNYv9qWZNTRb</article-id>
      <article-id specific-use="scielo-v2" pub-id-type="publisher-id">S0066-782X2025001000801</article-id>
      <article-id pub-id-type="other">00801</article-id>
      <article-id pub-id-type="doi">10.36660/abc.20250163</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Comunica&#231;&#227;o Breve</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pericardite Constritiva com Necrose Caseosa: Uma Apresenta&#231;&#227;o Rara e Pouco Conhecida</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-7545-2683</contrib-id>
          <name>
            <surname>Wolf</surname>
            <given-names>Pl&#237;nio Jos&#233; Whitaker</given-names>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa</role>
          <role>An&#225;lise e interpreta&#231;&#227;o dos dados</role>
          <role>An&#225;lise estat&#237;stica</role>
          <role>Reda&#231;&#227;o do manuscrito e Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do</role>
          <role>Obten&#231;&#227;o de financiamento</role>
          <role>Obten&#231;&#227;o de dados</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Correia</surname>
            <given-names>Edileide Barros</given-names>
          </name>
          <role>Concep&#231;&#227;o e desenho da pesquisa</role>
          <role>An&#225;lise e interpreta&#231;&#227;o dos dados</role>
          <role>An&#225;lise estat&#237;stica</role>
          <role>Reda&#231;&#227;o do manuscrito e Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do</role>
          <role>Obten&#231;&#227;o de dados</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vasconcellos</surname>
            <given-names>Marcos de Oliveira</given-names>
          </name>
          <role>Obten&#231;&#227;o de dados</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-3799-9466</contrib-id>
          <name>
            <surname>Bruscky</surname>
            <given-names>Larissa Ventura Ribeiro</given-names>
          </name>
          <role>Obten&#231;&#227;o de dados</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-7909-5326</contrib-id>
          <name>
            <surname>Murta</surname>
            <given-names>Ana Cristina de Souza</given-names>
          </name>
          <role>Obten&#231;&#227;o de dados</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Francisco</surname>
            <given-names>Yon&#225; Afonso</given-names>
          </name>
          <role>Obten&#231;&#227;o de dados</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sassaki</surname>
            <given-names>Eduardo Mikio</given-names>
          </name>
          <role>Obten&#231;&#227;o de dados</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Domingos</surname>
            <given-names>Sara Regina Alcalde</given-names>
          </name>
          <role>Obten&#231;&#227;o de dados</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Donadon</surname>
            <given-names>Natan Alevato</given-names>
          </name>
          <role>Obten&#231;&#227;o de dados</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miranda</surname>
            <given-names>Gerson</given-names>
          </name>
          <role>Obten&#231;&#227;o de dados</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rossi</surname>
            <given-names>Raphael</given-names>
          </name>
          <role>Obten&#231;&#227;o de dados</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0009-0009-7061-0238</contrib-id>
          <name>
            <surname>Mattos</surname>
            <given-names>Victor Bemfica de Mello</given-names>
          </name>
          <role>Obten&#231;&#227;o de dados</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fortuna</surname>
            <given-names>Fernanda de Brito</given-names>
          </name>
          <role>Obten&#231;&#227;o de dados</role>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution content-type="orgname">Instituto Dante Pazzanese de Cardiologia</institution>
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">SP</named-content>
        </addr-line>
        <country country="BR">Brasil</country>
        <institution content-type="original">Instituto Dante Pazzanese de Cardiologia, S&#227;o Paulo, SP &#8211; Brasil</institution>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution content-type="orgname">Centro de Refer&#234;ncia e Treinamento DST/Aids-SP</institution>
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">SP</named-content>
        </addr-line>
        <country country="BR">Brasil</country>
        <institution content-type="original">Centro de Refer&#234;ncia e Treinamento DST/Aids-SP, S&#227;o Paulo, SP &#8211; Brasil</institution>
      </aff>
      <author-notes>
        <corresp id="c01"><label>Correspond&#234;ncia:</label> Pl&#237;nio Jos&#233; Whitaker Wolf Instituto Dante Pazzanese de Cardiologia &#8211; Mioc&#225;rdio &#8211; Av. Doutor Dante Pazzanese, 500. CEP 04012-909, S&#227;o Paulo, SP &#8211; Brasil E-mail: <email>Pjwwolf@hotmail.com</email> </corresp>
        <fn fn-type="coi-statement">
          <label>Potencial conflito de interesse:</label>
          <p>N&#227;o h&#225; conflito com o presente artigo.</p>
        </fn>
        <fn fn-type="edited-by">
          <label>Editor respons&#225;vel pela revis&#227;o:</label>
          <p>Nuno Bettencourt</p>
        </fn>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>19</day>
        <month>12</month>
        <year>2025</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <month>11</month>
        <year>2025</year>
      </pub-date>
      <volume>122</volume>
      <issue>10</issue>
      <elocation-id>e20250163</elocation-id>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>03</month>
          <year>2025</year>
        </date>
        <date date-type="rev-recd">
          <day>18</day>
          <month>06</month>
          <year>2025</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>08</month>
          <year>2025</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p>Este &#233; um artigo de acesso aberto distribu&#237;do sob os termos da licen&#231;a de atribui&#231;&#227;o pelo Creative Commons</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Resumo</title>
        <p>D&#225;-se o nome de necrose caseosa da v&#225;lvula mitral &#224; ocorr&#234;ncia de liquefa&#231;&#227;o do c&#225;lcio presente em seu anel fibroso e consequente forma&#231;&#227;o de um pseudotumor com conte&#250;do pastoso e espesso em seu interior. Apesar de raro, tal processo degenerativo j&#225; &#233; amplamente descrito no contexto da valva mitral, contudo, &#233; pouco conhecido na condi&#231;&#227;o da pericardite constritiva. Descrevemos uma s&#233;rie de sete casos que apresentaram quadro de pericardite constritiva associada &#224; necrose caseosa. Dos sete pacientes, seis eram masculinos, com idade m&#233;dia de 42&#177;14 anos, todos em classe funcional III/IV, com cl&#237;nica relacionada &#224; s&#237;ndrome restritiva. A tomografia de t&#243;rax evidenciou intensa calcifica&#231;&#227;o peric&#225;rdica com necrose caseosa, confirmada pela pericardiectomia.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <p>
          <fig id="f01">
            <label>Figura Central:</label>
            <caption>
              <title>Pericardite Constritiva com Necrose Caseosa: Uma Apresenta&#231;&#227;o Rara e Pouco Conhecida</title>
            </caption>
            <attrib>Tomografias comp. de t&#243;rax demonstrando pericardite constritiva calcificada com necrose caseosa. Setas amarelas destacando &#225;reas com necrose caseosa.</attrib>
            <alternatives>
              <graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/qqkKmwpkkRfwNYv9qWZNTRb/67bcc5a08b014d8009a1d620fcd6a96b2ef0795b.tif"/>
              <graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/qqkKmwpkkRfwNYv9qWZNTRb/4c9643c8966af616e9f91682a21efa55e7c92862.png" specific-use="scielo-web"/>
              <graphic xlink:href="https://minio.scielo.br/documentstore/1678-4170/qqkKmwpkkRfwNYv9qWZNTRb/c7c3fc73b28895875b2efbcabd5bb817e7cb96f0.jpg" specific-use="scielo-web" content-type="scielo-267x140"/>
            </alternatives>
          </fig>
        </p>
      </abstract>
      <kwd-group xml:lang="pt">
        <title>Palavras-chave</title>
        <kwd>Pericardite Constritiva</kwd>
        <kwd>Peric&#225;rdio</kwd>
        <kwd>Insufici&#234;ncia Card&#237;aca</kwd>
      </kwd-group>
      <funding-group>
        <funding-statement> O presente estudo n&#227;o teve fontes de financiamento externas.</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="4"/>
        <table-count count="2"/>
        <equation-count count="0"/>
        <ref-count count="15"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introdu&#231;&#227;o</title>
      <p>A calcifica&#231;&#227;o do anel mitral (CAM) &#233; definida como uma degenera&#231;&#227;o cr&#244;nica do anel fibroso da valva,<sup><xref ref-type="bibr" rid="B1">1</xref></sup> sendo a necrose caseosa (NC) do anel mitral (NCVM), por sua vez, uma rara variante desta condi&#231;&#227;o, em que ocorre liquefa&#231;&#227;o do conte&#250;do calcificado dessa estrutura.<sup><xref ref-type="bibr" rid="B2">2</xref></sup> A NC, j&#225; amplamente descrita na valva mitral, &#233; rara e pouco reconhecida no contexto da pericardite constritiva (PC) calcificada.</p>
      <p>Descrevemos uma s&#233;rie de casos evidenciando essa incomum associa&#231;&#227;o entre a PC e a NC.</p>
    </sec>
    <sec sec-type="cases">
      <title>Relato de Casos</title>
      <p>Descrevemos sete pacientes portadores de PC associada &#224; NC, de maneira observacional e retrospectiva, em centro &#250;nico, refer&#234;ncia em cardiomiopatias no Brasil. Dentre eles, seis eram masculinos, com idade m&#233;dia de 42&#177;14 anos. A presen&#231;a de comorbidades foi infrequente, verificada em quatro deles, sendo as mais comuns, o hipotireoidismo e o tabagismo (<xref ref-type="table" rid="t1">Tabela 1</xref>).</p>
      <p>
        <table-wrap id="t1">
          <label>Tabela 1</label>
          <caption>
            <title>&#8211; Caracter&#237;sticas basais cl&#237;nicas, ecocardiogr&#225;ficas, laboratoriais e anatomopatol&#243;gicas</title>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup>
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
              <col/>
            </colgroup>
            <thead>
              <tr>
                <th>Paciente</th>
                <th>Sexo/Idade</th>
                <th>AP</th>
                <th>CF (NYHA) Pr&#233; Cx</th>
                <th>In&#237;cio queixa (meses)</th>
                <th>ECOTT Pr&#233; Cx</th>
                <th>FEVE Ap&#243;s Cx</th>
                <th>FA</th>
                <th align="left">Bi&#243;psia Peric&#225;rdica</th>
                <th>PCR (mg/dL)</th>
                <th>NT-pro BNP (pg/mL)</th>
                <th>CF (NYHA) Ap&#243;s Cx</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="center">P1</td>
                <td align="center">M 62 anos</td>
                <td align="center">HipoT, Obesidade, HAS, DRC</td>
                <td align="center">III</td>
                <td align="center">2</td>
                <td align="center">FEVE: 66%; AE: 50 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>; PSAP: ausente; AR+/SB+</td>
                <td align="center">59%</td>
                <td align="center">Sim</td>
                <td>Pericardite cr&#244;nica, fibrose e calcifica&#231;&#227;o. Sem malignidade ou granuloma</td>
                <td align="center">2,0</td>
                <td align="center">2350</td>
                <td align="center">II</td>
              </tr>
              <tr>
                <td align="center">P2</td>
                <td align="center">M 35 anos</td>
                <td align="center">Ausente</td>
                <td align="center">III</td>
                <td align="center">2</td>
                <td align="center">FEVE: 58%; AE: 26 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>; PSAP: ausente; AR+/SB+</td>
                <td align="center">61%</td>
                <td align="center">N&#227;o</td>
                <td>Pericardite cr&#244;nica, fibrose e calcifica&#231;&#227;o. Sem malignidade ou granuloma</td>
                <td align="center">1,9</td>
                <td align="center">115</td>
                <td align="center">I</td>
              </tr>
              <tr>
                <td align="center">P3</td>
                <td align="center">M 38 anos</td>
                <td align="center">Tabagismo</td>
                <td align="center">IV</td>
                <td align="center">24</td>
                <td align="center">FEVE: 58%; AE: 61 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>; PSAP: 39 mmHg; Disfun&#231;&#227;o VD; AR+/SB+</td>
                <td align="center">60%</td>
                <td align="center">N&#227;o</td>
                <td>Pericardite cr&#244;nica, fibrose e calcifica&#231;&#227;o. Sem malignidade ou granuloma</td>
                <td align="center">0,5</td>
                <td align="center">1329</td>
                <td align="center">III</td>
              </tr>
              <tr>
                <td align="center">P4</td>
                <td align="center">F 60 anos</td>
                <td align="center">HipoT, DLP, HAS</td>
                <td align="center">III</td>
                <td align="center">24</td>
                <td align="center">FEVE: 62%; AE: 50 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>; PSAP: 35 mmHg; AR+/SB+</td>
                <td align="center">62%</td>
                <td align="center">N&#227;o</td>
                <td>Pericardite cr&#244;nica, fibrose e calcifica&#231;&#227;o. Sem malignidade ou granuloma</td>
                <td align="center">0,5</td>
                <td align="center">1500</td>
                <td align="center">I</td>
              </tr>
              <tr>
                <td align="center">P5</td>
                <td align="center">M 40 anos</td>
                <td align="center">Ausente</td>
                <td align="center">III</td>
                <td align="center">12</td>
                <td align="center">FEVE: 46%; AE: 43 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>; PSAP: 34 mmHg; Disfun&#231;&#227;o VD; AR+/SB+</td>
                <td align="center">47%</td>
                <td align="center">N&#227;o</td>
                <td>Pericardite cr&#244;nica, fibrose e calcifica&#231;&#227;o. Sem malignidade ou granuloma</td>
                <td align="center">0,9</td>
                <td align="center">135</td>
                <td align="center">II</td>
              </tr>
              <tr>
                <td align="center">P6</td>
                <td align="center">M 39 anos</td>
                <td align="center">HipoT, DRC</td>
                <td align="center">III</td>
                <td align="center">24</td>
                <td align="center">FEVE: 24%; AE: 65 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>; PSAP: 40 mmHg; Disfun&#231;&#227;o VD; AR+/SB+</td>
                <td align="center">50%</td>
                <td align="center">Sim</td>
                <td>Pericardite cr&#244;nica, fibrose e calcifica&#231;&#227;o, degenera&#231;&#227;o mixoide. Sem malignidade ou granuloma</td>
                <td align="center">0,5</td>
                <td align="center">1650</td>
                <td align="center">I</td>
              </tr>
              <tr>
                <td align="center">P7</td>
                <td align="center">M 22 anos</td>
                <td align="center">Ausente</td>
                <td align="center">II</td>
                <td align="center">6</td>
                <td align="center">FEVE: 65%; AE: 46 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>; PSAP: NA; AR+/SB+</td>
                <td align="center">65%</td>
                <td align="center">N&#227;o</td>
                <td>Pericardite cr&#244;nica, fibrose e calcifica&#231;&#227;o. Sem malignidade ou granuloma</td>
                <td align="center">1,8</td>
                <td align="center">NA</td>
                <td align="center">I</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN1">
              <p>*&gt;3 meses da cirurgia. AP: antecedentes pessoais; AR: annulus reverso; AE: volume &#225;trio esquerdo; CF: classe funcional; Cx: cirurgia; DLP: dislipidemia; DRC: doen&#231;a renal cr&#244;nica; ECOTT: ecocardiograma transtor&#225;cico; FA: fibrila&#231;&#227;o atrial; FEVE: fra&#231;&#227;o de eje&#231;&#227;o de ventr&#237;culo esquerdo; HAS: hipertens&#227;o arterial sist&#234;mica; HipoT: hipotireoidismo; IC: insufici&#234;ncia card&#237;aca; PCR: prote&#237;na C reativa; PSAP: press&#227;o sist&#243;lica art&#233;ria pulmonar; NA: n&#227;o avaliado; NT-pro BNP: por&#231;&#227;o N-terminal proBNP; NYHA: New York Heart Association; SB: septal bounce; VD: ventr&#237;culo direito.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </p>
      <p>S&#237;ndrome restritiva foi a manifesta&#231;&#227;o inicial de forma un&#226;nime, expressa por dispneia progressiva, classe funcional III/IV da NYHA, predominando os sinais de insufici&#234;ncia card&#237;aca (IC) direita, estando presente, na totalidade dos casos, edema de membros inferiores, ascite, derrame pleural, hepatomegalia, turg&#234;ncia jugular e refluxo hepatojugular. N&#227;o houve descri&#231;&#227;o de sinal de Kussmaul ou pulso paradoxal em nenhum dos pacientes. O tempo m&#233;dio entre o in&#237;cio dos sintomas e a admiss&#227;o hospitalar foi de pelo menos 2 meses (m&#233;dia de 13,4&#177;10,4 meses), denotando quadro cl&#237;nico arrastado e progressivo.</p>
      <p>N&#227;o foram observadas altera&#231;&#245;es importantes nos exames laboratoriais, incluindo a contagem de leuc&#243;citos e prote&#237;na C reativa (PCR) (1,15&#177;0,7 mg/dL). O NT-proBNP m&#233;dio foi de 1179&#177;887 pg/mL.</p>
      <p>O ecocardiograma transtor&#225;cico (ECOTT), confirmou o diagn&#243;stico de PC, com os achados t&#237;picos de peric&#225;rdio espessado, calcificado, al&#233;m de sinais de interdepend&#234;ncia ventricular. A fra&#231;&#227;o de eje&#231;&#227;o de ventr&#237;culo esquerdo (FEVE) se encontrava reduzida (inferior a 40%) em apenas um paciente, com m&#233;dia de 54&#177;14,8%, entretanto, em 42% dos casos, havia disfun&#231;&#227;o do ventr&#237;culo direito (VD). Outros achados foram aumento de &#225;trio esquerdo (85%), com volume m&#233;dio de 48&#177;12 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref> e hipertens&#227;o pulmonar (57%). Foram visualizadas imagens hiperecog&#234;nicas heterog&#234;neas, aderidas ao peric&#225;rdio, gerando restri&#231;&#227;o das c&#226;maras, sobretudo o VD.</p>
      <p>A radiografia de t&#243;rax demonstrava radiopacidade contornando a silhueta card&#237;aca. A tomografia computadorizada de t&#243;rax (TC) (<xref ref-type="fig" rid="f02">Figura 1</xref>) confirmou espessamento peric&#225;rdico com hiperdensidade importante, associado a &#8220;pseudotumores&#8221; com contornos irregulares e conte&#250;do heterog&#234;neo mais hipodenso em seu interior, causando abaulamento da silhueta card&#237;aca.</p>
      <p>
        <fig id="f02">
          <label>Figura 1</label>
          <caption>
            <title>&#8211; Tomografias comp. de t&#243;rax demonstrando pericardite constritiva calcificada com necrose caseosa. Tomografias de t&#243;rax evidenciando peric&#225;rdio espessado, calcificado, associado a &#8220;pseudotumores&#8221; com contornos irregulares de conte&#250;do heterog&#234;neo hipodenso (setas amarelas). &#8220;Paciente 7A&#8221; e &#8220;Paciente 7B&#8221; se referem ao mesmo paciente, antes e ap&#243;s a pericardiectomia, respectivamente.</title>
          </caption>
          <graphic xlink:href="1678-4170-abc-122-10-e20250163-50163-gf01.tif"/></fig>
      </p>
      <p>No intraoperat&#243;rio da pericardiectomia, realizada em todos, foi constatado peric&#225;rdio espessado, r&#237;gido, calcificado e aderido &#224;s estruturas adjacentes. Observou-se exposi&#231;&#227;o de subst&#226;ncia esbranqui&#231;ada, pastosa, semelhante a &#8220;pasta-de-dente&#8221;, em moderada-grande quantidade, surgida dos &#8220;pseudotumores&#8221; presentes no peric&#225;rdio, a chamada NC ou o &#8220;caseum&#8221;. Evidenciou-se recupera&#231;&#227;o da fun&#231;&#227;o ventricular ap&#243;s o procedimento.</p>
      <p>No p&#243;s-operat&#243;rio tardio, todos apresentaram melhora significativa dos sintomas, evoluindo, em sua maioria, para classe funcional NYHA I-II, principalmente a partir dos 3 meses da cirurgia. A FEVE reduzida, observada em um &#250;nico paciente, normalizou-se ap&#243;s 24 horas da cirurgia (24% para 50%). Todos se mantiveram oligossintom&#225;ticos no seguimento m&#233;dio de 2,7 anos.</p>
      <p>Os pacientes foram avaliados quanto &#224; etiologia da pericardite, incluindo tuberculose (TB), por meio da an&#225;lise an&#225;tomo patol&#243;gica do peric&#225;rdio, onde n&#227;o foram evidenciados, em nenhum dos pacientes, granulomas ou malignidade. Baciloscopia e cultura para micobact&#233;ria negativas nos materiais, al&#233;m de aus&#234;ncia de manifesta&#231;&#245;es cl&#237;nicas, pr&#233;vias ou posteriores (febre, tosse, perda de peso e sudorese noturna) que sugerissem doen&#231;as infecciosas em atividade, como a TB.</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discuss&#227;o</title>
      <p>Descrevemos sete casos da rara e pouco reconhecida associa&#231;&#227;o da NC com a PC, cuja descri&#231;&#227;o &#233; escassa na literatura, reportada em apenas uma publica&#231;&#227;o.<sup><xref ref-type="bibr" rid="B3">3</xref></sup></p>
      <p>No entanto, a descri&#231;&#227;o desse processo degenerativo j&#225; &#233; definitivamente consolidada no que diz respeito ao anel mitral.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref></sup> A CAM ocorre em 8 a 15% da popula&#231;&#227;o geral,<sup><xref ref-type="bibr" rid="B6">6</xref></sup> enquanto que a NCVM, mais rara, tem uma preval&#234;ncia ainda desconhecida e subestimada, ocorrendo em torno 0,06-0,07%,<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref></sup> e &#233; mais prevalente em mulheres, idosos, hipertensos, doentes renais cr&#244;nicos e naqueles com altera&#231;&#245;es no metabolismo do c&#225;lcio.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref></sup> Geralmente &#233; assintom&#225;tica e a multimodalidade de imagem &#233; fundamental para o diagn&#243;stico.<sup><xref ref-type="bibr" rid="B2">2</xref></sup></p>
      <p>Neste estudo, diferindo da NC confinada &#224; valva mitral j&#225; amplamente reconhecida, descrevemos a ocorr&#234;ncia da mesma na PC calcificada. A PC &#233; caracterizada por uma inflama&#231;&#227;o do peric&#225;rdio que, na maioria das vezes, leva &#224; fibrose, com ou sem calcifica&#231;&#227;o, perdendo sua elasticidade, levando &#224; disfun&#231;&#227;o diast&#243;lica ventricular.<sup><xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B9">9</xref></sup> De fato, pode ocorrer ap&#243;s qualquer processo patol&#243;gico peric&#225;rdico, cujo risco de progress&#227;o para PC &#233; dependente da etiologia: baixo (&lt;1%) na pericardite viral/idiop&#225;tica, intermedi&#225;rio (2-5%) nas causas neopl&#225;sicas/autoimunes e alto (20-30%) em etiologias bacterianas. Registros de pa&#237;ses desenvolvidos demonstram que as principais causas incluem as cirurgias card&#237;acas (11-37%), radioterapia (9-31%) e etiologias viral ou idiop&#225;tica (42-49%). A tuberculose, embora causa rara de pericardite nesses pa&#237;ses (&lt;4%), ainda &#233; considerada uma cl&#225;ssica etiologia em regi&#245;es menos desenvolvidas (50-70%), evoluindo, mesmo com tratamento adequado, &#224; PC em 17 a 40% dos casos.<sup><xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B12">12</xref></sup> Independentemente da etiologia, o espessamento e a perda da elasticidade do peric&#225;rdio levam a um estado de interdepend&#234;ncia ventricular, bem como a uma redu&#231;&#227;o de complac&#234;ncia peric&#225;rdica, com consequente redu&#231;&#227;o do enchimento das c&#226;maras card&#237;acas e do retorno venoso (refletindo em sinais e sintomas de s&#237;ndrome restritiva, sobretudo a direita, conforme apresentaram os pacientes relatados).<sup><xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B12">12</xref></sup> Os sinais e sintomas de IC direita podem ser encontrados em outros diagn&#243;sticos diferenciais, como a cardiomiopatia restritiva,<sup><xref ref-type="bibr" rid="B8">8</xref></sup> mas os evidentes achados ecocardiogr&#225;ficos dos sete pacientes relacionados &#224; interdepend&#234;ncia ventricular, <italic>septal bounce</italic> e <italic>annulus</italic> reverso, associados &#224; doen&#231;a peric&#225;rdica evidente, trouxeram a confirma&#231;&#227;o diagn&#243;stica de PC.</p>
      <p>Na PC, o peric&#225;rdio se encontra espessado em 80% dos casos<sup><xref ref-type="bibr" rid="B9">9</xref></sup> e calcificado em 11 a 70% das situa&#231;&#245;es, sobretudo em casos de PC idiop&#225;tica, relacionada &#224; radia&#231;&#227;o ou TB.<sup><xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref></sup> Na casu&#237;stica, o peric&#225;rdio se encontrava espessado e calcificado na totalidade dos pacientes. Al&#233;m disso, foi observada a presen&#231;a de estruturas compat&#237;veis com &#8220;pseudotumores&#8221; no peric&#225;rdio nos exames de imagem, cujo conte&#250;do era composto pelo &#8220;caseum&#8221;, confirmado na cirurgia, configurando a NC.</p>
      <p>O mecanismo fisiopatol&#243;gico da NC n&#227;o &#233; completamente compreendido. A hip&#243;tese levantada na NCVM lastreia-se na liquefa&#231;&#227;o do material calcificado do anel mitral. A hipercolesterolemia e macr&#243;fagos carregados de lip&#237;deos poderiam levar &#224; forma&#231;&#227;o de uma cavidade com material pastoso, semelhante &#224; apar&#234;ncia de &#8220;pasta-de-dente&#8221;, composta por &#225;cidos graxos, colesterol e c&#225;lcio.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B14">14</xref></sup> Acreditamos que, nos casos de PC calcificada, mecanismo fisiopatol&#243;gico semelhante esteja envolvido, pela intensa calcifica&#231;&#227;o compartilhada nesses cen&#225;rios.</p>
      <p>O car&#225;ter cr&#244;nico da condi&#231;&#227;o pode ser inferido pelo longo tempo dos sintomas associado a baixa inflama&#231;&#227;o sist&#234;mica, refletido pelas reduzidas dosagens de PCR.</p>
      <p>Os n&#237;veis de pept&#237;deos natriur&#233;ticos n&#227;o foram correlacionados &#224; gravidade dos sintomas, provavelmente pela restri&#231;&#227;o da dilata&#231;&#227;o das c&#226;maras card&#237;acas pela pericardite, como j&#225; descrito previamente em outras publica&#231;&#245;es no contexto da PC.<sup><xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref></sup> Observou-se melhora cl&#237;nica muito expressiva ap&#243;s a pericardiectomia, permanecendo 85% dos pacientes em NYHA&#8804;II, associado a aus&#234;ncia de &#243;bitos ocorridos no periprocedimento (a literatura relata mortalidade em torno de 6-12%<sup><xref ref-type="bibr" rid="B10">10</xref></sup>), o que reafirma a crescente indica&#231;&#227;o (incremento na realiza&#231;&#227;o de pericardiectomia de 2% para 34% na PC) e o benef&#237;cio desse procedimento, mesmo diante de intensa calcifica&#231;&#227;o e NC.<sup><xref ref-type="bibr" rid="B12">12</xref></sup></p>
      <p>Em rela&#231;&#227;o &#224; etiologia, esta foi considerada idiop&#225;tica em todos os casos, sendo exclu&#237;das tuberculose e malignidade, al&#233;m de outras causas trat&#225;veis, por meio da avalia&#231;&#227;o laboratorial, do hist&#243;rico cl&#237;nico e pela an&#225;lise do material da bi&#243;psia, que confirmou calcifica&#231;&#227;o, fibrose e inflama&#231;&#227;o inespec&#237;fica. Tais achados corroboram com a possibilidade de que a PC possa ocorrer em consequ&#234;ncia de qualquer agress&#227;o peric&#225;rdica<sup><xref ref-type="bibr" rid="B9">9</xref></sup> e reflete outras s&#233;ries de casos PC calcificada, onde a causa idiop&#225;tica foi a mais prevalente.<sup><xref ref-type="bibr" rid="B15">15</xref></sup> Ressalta-se que, apesar da TB ser uma importante causa de PC em pa&#237;ses subdesenvolvidos (sendo, portanto, essencial seu rastreio), o achado de NC na PC n&#227;o tem rela&#231;&#227;o direta com essa etiologia e nem mesmo com seus t&#237;picos granulomas caseosos. Embora haja similaridade na nomenclatura, a NC em quest&#227;o &#233; secund&#225;ria &#224; liquefa&#231;&#227;o do material calcificado, n&#227;o sendo um processo exclusivo da atividade da TB.<sup><xref ref-type="bibr" rid="B1">1</xref></sup></p>
      <p>Conclu&#237;mos que a ocorr&#234;ncia de NC pode estar presente nos casos de intensa calcifica&#231;&#227;o peric&#225;rdica e que sua ocorr&#234;ncia n&#227;o implica em mudan&#231;a de estrat&#233;gia terap&#234;utica e progn&#243;stico. O entendimento aprofundado desta condi&#231;&#227;o demanda mais estudos, entretanto, o pioneirismo dessa s&#233;rie de casos pode contribuir para posteriores discuss&#245;es e pesquisas.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>Refer&#234;ncias</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1. Elgendy IY, Conti CR. Caseous Calcification of the Mitral Annulus: A Review. Clin Cardiol. 2013;36(10):E27-31. doi: 10.1002/clc.22199.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elgendy</surname>
              <given-names>IY</given-names>
            </name>
            <name>
              <surname>Conti</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
          <article-title>Caseous Calcification of the Mitral Annulus: A Review</article-title>
          <source>Clin Cardiol</source>
          <year>2013</year>
          <volume>36</volume>
          <issue>10</issue>
          <fpage>E27</fpage>
          <lpage>E31</lpage>
          <pub-id pub-id-type="doi">10.1002/clc.22199</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2. Joaquim RM, Correia EB, Bezerra SL, Pinto IMF, Santos TSG, Albrecht FC. Caseous Necrosis of the Mitral Valve: Imaging Methods Allow Diagnosis and Prevent Surgery. Int J Cardiovasc Sci. 2017;30(2):177-80. doi: 10.5935/2359-4802.20170021.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Joaquim</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Correia</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Bezerra</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Pinto</surname>
              <given-names>IMF</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>TSG</given-names>
            </name>
            <name>
              <surname>Albrecht</surname>
              <given-names>FC</given-names>
            </name>
          </person-group>
          <article-title>Caseous Necrosis of the Mitral Valve: Imaging Methods Allow Diagnosis and Prevent Surgery</article-title>
          <source>Int J Cardiovasc Sci</source>
          <year>2017</year>
          <volume>30</volume>
          <issue>2</issue>
          <fpage>177</fpage>
          <lpage>180</lpage>
          <pub-id pub-id-type="doi">10.5935/2359-4802.20170021</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3. Volpe MA, Paredes JEM, Maron E, Sanchez ISM, Oliveira JAP, Silveira LZD. Constrictive Pericarditis with Extensive Calcification and Caseous Necrosis. Braz J Cardiovasc Surg. 2020;35(4):580-3. doi: 10.21470/1678-9741-2019-0224.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Volpe</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Paredes</surname>
              <given-names>JEM</given-names>
            </name>
            <name>
              <surname>Maron</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sanchez</surname>
              <given-names>ISM</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>JAP</given-names>
            </name>
            <name>
              <surname>Silveira</surname>
              <given-names>LZD</given-names>
            </name>
          </person-group>
          <article-title>Constrictive Pericarditis with Extensive Calcification and Caseous Necrosis</article-title>
          <source>Braz J Cardiovasc Surg</source>
          <year>2020</year>
          <volume>35</volume>
          <issue>4</issue>
          <fpage>580</fpage>
          <lpage>583</lpage>
          <pub-id pub-id-type="doi">10.21470/1678-9741-2019-0224</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4. Deluca G, Correale M, Ieva R, Del Salvatore B, Gramenzi S, Di Biase M. The Incidence and Clinical Course of Caseous Calcification of the Mitral Annulus: A Prospective Echocardiographic Study. J Am Soc Echocardiogr. 2008;21(7):828-33. doi: 10.1016/j.echo.2007.12.004.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deluca</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Correale</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ieva</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Del Salvatore</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gramenzi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Di Biase</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The Incidence and Clinical Course of Caseous Calcification of the Mitral Annulus: A Prospective Echocardiographic Study</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2008</year>
          <volume>21</volume>
          <issue>7</issue>
          <fpage>828</fpage>
          <lpage>833</lpage>
          <pub-id pub-id-type="doi">10.1016/j.echo.2007.12.004</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation>5. Harpaz D, Auerbach I, Vered Z, Motro M, Tobar A, Rosenblatt S. Caseous Calcification of the Mitral Annulus: A Neglected, Unrecognized Diagnosis. J Am Soc Echocardiogr. 2001;14(8):825-31. doi: 10.1067/mje.2001.111877.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harpaz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Auerbach</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Vered</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Motro</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tobar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rosenblatt</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Caseous Calcification of the Mitral Annulus: A Neglected, Unrecognized Diagnosis</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2001</year>
          <volume>14</volume>
          <issue>8</issue>
          <fpage>825</fpage>
          <lpage>831</lpage>
          <pub-id pub-id-type="doi">10.1067/mje.2001.111877</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation>6. Abramowitz Y, Jilaihawi H, Chakravarty T, Mack MJ, Makkar RR. Mitral Annulus Calcification. J Am Coll Cardiol. 2015;66(17):1934-41. doi: 10.1016/j.jacc.2015.08.872.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abramowitz</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Jilaihawi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chakravarty</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mack</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Makkar</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>Mitral Annulus Calcification</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2015</year>
          <volume>66</volume>
          <issue>17</issue>
          <fpage>1934</fpage>
          <lpage>1941</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jacc.2015.08.872</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation>7. Kaur J, Xu J, Alturkmani HJ, Al'Aref S, Dhar G. Severely Calcified Pericardium Causing Constrictive Pericarditis. Methodist Debakey Cardiovasc J. 2023;19(1):7-11. doi: 10.14797/mdcvj.1183.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaur</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Alturkmani</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Al'Aref</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dhar</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Severely Calcified Pericardium Causing Constrictive Pericarditis</article-title>
          <source>Methodist Debakey Cardiovasc J</source>
          <year>2023</year>
          <volume>19</volume>
          <issue>1</issue>
          <fpage>7</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="doi">10.14797/mdcvj.1183</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation>8. Johnen J, Radermecker MA, Defraigne JO. Constrictive Pericarditis: Case Report and Review. Rev Med Liege. 2012;67(3):107-12.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johnen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Radermecker</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Defraigne</surname>
              <given-names>JO</given-names>
            </name>
          </person-group>
          <article-title>Constrictive Pericarditis: Case Report and Review</article-title>
          <source>Rev Med Liege</source>
          <year>2012</year>
          <volume>67</volume>
          <issue>3</issue>
          <fpage>107</fpage>
          <lpage>112</lpage>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation>9. Adler Y, Charron P, Imazio M, Badano L, Bar&#243;n-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921-64. doi: 10.1093/eurheartj/ehv318.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adler</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Charron</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Imazio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Badano</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bar&#243;n-Esquivias</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bogaert</surname>
              <given-names>J</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)</article-title>
          <source>Eur Heart J</source>
          <year>2015</year>
          <volume>36</volume>
          <issue>42</issue>
          <fpage>2921</fpage>
          <lpage>2964</lpage>
          <pub-id pub-id-type="doi">10.1093/eurheartj/ehv318</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation>10. Schwefer M, Aschenbach R, Heidemann J, Mey C, Lapp H. Constrictive Pericarditis, Still a Diagnostic Challenge: Comprehensive Review of Clinical Management. Eur J Cardiothorac Surg. 2009;36(3):502-10. doi: 10.1016/j.ejcts.2009.03.004.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwefer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aschenbach</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Heidemann</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mey</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lapp</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Constrictive Pericarditis, Still a Diagnostic Challenge: Comprehensive Review of Clinical Management</article-title>
          <source>Eur J Cardiothorac Surg</source>
          <year>2009</year>
          <volume>36</volume>
          <issue>3</issue>
          <fpage>502</fpage>
          <lpage>510</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejcts.2009.03.004</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation>11. Nishimura RA. Constrictive Pericarditis in the Modern Era: A Diagnostic Dilemma. Heart. 2001;86(6):619-23. doi: 10.1136/heart.86.6.619.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishimura</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Constrictive Pericarditis in the Modern Era: A Diagnostic Dilemma</article-title>
          <source>Heart</source>
          <year>2001</year>
          <volume>86</volume>
          <issue>6</issue>
          <fpage>619</fpage>
          <lpage>623</lpage>
          <pub-id pub-id-type="doi">10.1136/heart.86.6.619</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation>12. Syed FF, Schaff HV, Oh JK. Constrictive Pericarditis--a Curable Diastolic Heart Failure. Nat Rev Cardiol. 2014;11(9):530-44. doi: 10.1038/nrcardio.2014.100.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Syed</surname>
              <given-names>FF</given-names>
            </name>
            <name>
              <surname>Schaff</surname>
              <given-names>HV</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>Constrictive Pericarditis--a Curable Diastolic Heart Failure</article-title>
          <source>Nat Rev Cardiol</source>
          <year>2014</year>
          <volume>11</volume>
          <issue>9</issue>
          <fpage>530</fpage>
          <lpage>544</lpage>
          <pub-id pub-id-type="doi">10.1038/nrcardio.2014.100</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation>13. Ianni BM, Mady C, Arteaga-Fern&#225;ndez E, Dauar D, Barretto AC, Bellotti G, et al. Chronic Constrictive Pericarditis. Importance of Non-Invasive Complementary Tests. Arq Bras Cardiol. 1984;43(2):87-91.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ianni</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Mady</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Arteaga-Fern&#225;ndez</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Dauar</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Barretto</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Bellotti</surname>
              <given-names>G</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Chronic Constrictive Pericarditis. Importance of Non-Invasive Complementary Tests</article-title>
          <source>Arq Bras Cardiol</source>
          <year>1984</year>
          <volume>43</volume>
          <issue>2</issue>
          <fpage>87</fpage>
          <lpage>91</lpage>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation>14. Stamou SC, Braverman AC, Kouchoukos NT. Caseous Calcification of the Anterior Mitral Valve Annulus Presenting as Intracardiac Mass. J Thorac Cardiovasc Surg. 2010;140(1):e9-e10. doi: 10.1016/j.jtcvs.2009.09.047.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stamou</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Braverman</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Kouchoukos</surname>
              <given-names>NT</given-names>
            </name>
          </person-group>
          <article-title>Caseous Calcification of the Anterior Mitral Valve Annulus Presenting as Intracardiac Mass</article-title>
          <source>J Thorac Cardiovasc Surg</source>
          <year>2010</year>
          <volume>140</volume>
          <issue>1</issue>
          <fpage>e9</fpage>
          <lpage>e10</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jtcvs.2009.09.047</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation>15. Ling LH, Oh JK, Breen JF, Schaff HV, Danielson GK, Mahoney DW, et al. Calcific Constrictive Pericarditis: Is it Still with Us? Ann Intern Med. 2000;132(6):444-50. doi: 10.7326/0003-4819-132-6-200003210-00004.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ling</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Breen</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Schaff</surname>
              <given-names>HV</given-names>
            </name>
            <name>
              <surname>Danielson</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Mahoney</surname>
              <given-names>DW</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Calcific Constrictive Pericarditis: Is it Still with Us?</article-title>
          <source>Ann Intern Med</source>
          <year>2000</year>
          <volume>132</volume>
          <issue>6</issue>
          <fpage>444</fpage>
          <lpage>450</lpage>
          <pub-id pub-id-type="doi">10.7326/0003-4819-132-6-200003210-00004</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn fn-type="other">
        <label>Vincula&#231;&#227;o acad&#234;mica:</label>
        <p> N&#227;o h&#225; vincula&#231;&#227;o deste estudo a programas de p&#243;s-gradua&#231;&#227;o.</p>
      </fn>
      <fn fn-type="other">
        <label>Aprova&#231;&#227;o &#233;tica e consentimento informado:</label>
        <p> Este estudo foi aprovado pelo Comit&#234; de &#201;tica do Instituto Dante Pazzanese de Cardiologia sob o n&#250;mero de protocolo CAAE: 85779125.3.0000.5462, parecer 7.405.668. Todos os procedimentos envolvidos nesse estudo est&#227;o de acordo com a Declara&#231;&#227;o de Helsinki de 1975, atualizada em 2013. O consentimento informado foi obtido de todos os participantes inclu&#237;dos no estudo.</p>
      </fn>
      <fn fn-type="other">
        <label>Uso de Intelig&#234;ncia Artificial:</label>
        <p> Os autores n&#227;o utilizaram ferramentas de intelig&#234;ncia artificial no desenvolvimento deste trabalho.</p>
      </fn>
      <fn fn-type="data-availability" specific-use="data-in-article">
        <label>Disponibilidade de Dados:</label>
        <p> Os conte&#250;dos subjacentes ao texto da pesquisa est&#227;o contidos no manuscrito.</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <label>Fontes de financiamento:</label>
        <p> O presente estudo n&#227;o teve fontes de financiamento externas.</p>
      </fn>
    </fn-group>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-id pub-id-type="doi">10.36660/abc.20250163i</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Brief Communication</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Constrictive Pericarditis with Caseous Necrosis: A Rare and Underrecognized Presentation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-7545-2683</contrib-id>
          <name>
            <surname>Wolf</surname>
            <given-names>Pl&#237;nio Jos&#233; Whitaker</given-names>
          </name>
          <role>Conception and design of the research</role>
          <role>Analysis and interpretation of the data</role>
          <role>Statistical analysis</role>
          <role>Writing of the manuscript and Critical revision of the manuscript for content</role>
          <role>Acquisition of data</role>
          <role>Obtaining financing</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Correia</surname>
            <given-names>Edileide Barros</given-names>
          </name>
          <role>Conception and design of the research</role>
          <role>Analysis and interpretation of the data</role>
          <role>Statistical analysis</role>
          <role>Writing of the manuscript and Critical revision of the manuscript for content</role>
          <role>Acquisition of data</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vasconcellos</surname>
            <given-names>Marcos de Oliveira</given-names>
          </name>
          <role>Acquisition of data</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-3799-9466</contrib-id>
          <name>
            <surname>Bruscky</surname>
            <given-names>Larissa Ventura Ribeiro</given-names>
          </name>
          <role>Acquisition of data</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0002-7909-5326</contrib-id>
          <name>
            <surname>Murta</surname>
            <given-names>Ana Cristina de Souza</given-names>
          </name>
          <role>Acquisition of data</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2001">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Francisco</surname>
            <given-names>Yon&#225; Afonso</given-names>
          </name>
          <role>Acquisition of data</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sassaki</surname>
            <given-names>Eduardo Mikio</given-names>
          </name>
          <role>Acquisition of data</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Domingos</surname>
            <given-names>Sara Regina Alcalde</given-names>
          </name>
          <role>Acquisition of data</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Donadon</surname>
            <given-names>Natan Alevato</given-names>
          </name>
          <role>Acquisition of data</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miranda</surname>
            <given-names>Gerson</given-names>
          </name>
          <role>Acquisition of data</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rossi</surname>
            <given-names>Raphael</given-names>
          </name>
          <role>Acquisition of data</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0009-0009-7061-0238</contrib-id>
          <name>
            <surname>Mattos</surname>
            <given-names>Victor Bemfica de Mello</given-names>
          </name>
          <role>Acquisition of data</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fortuna</surname>
            <given-names>Fernanda de Brito</given-names>
          </name>
          <role>Acquisition of data</role>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1001">
        <label>1</label>
        <country country="BR">Brazil</country>
        <institution content-type="original">Instituto Dante Pazzanese de Cardiologia, S&#227;o Paulo, SP &#8211; Brazil</institution>
      </aff>
      <aff id="aff2001">
        <label>2</label>
        <country country="BR">Brazil</country>
        <institution content-type="original">Centro de Refer&#234;ncia e Treinamento DST/Aids-SP, S&#227;o Paulo, SP &#8211; Brazil</institution>
      </aff>
      <author-notes>
        <corresp id="c01001"><label>Mailing Address:</label>Pl&#237;nio Jos&#233; Whitaker Wolf Instituto Dante Pazzanese de Cardiologia &#8211; Mioc&#225;rdio &#8211; Av. Doutor Dante Pazzanese, 500. Postal Code 04012-909, S&#227;o Paulo, SP &#8211; Brazil E-mail: Pjwwolf@hotmail.com </corresp>
        <fn fn-type="coi-statement">
          <label>Potential conflict of interest:</label>
          <p>No potential conflict of interest relevant to this article was reported.</p>
        </fn>
        <fn fn-type="edited-by">
          <label>Editor responsible for the review:</label>
          <p>Nuno Bettencourt</p>
        </fn>
      </author-notes>
      <abstract>
        <title>Abstract</title>
        <p>Caseous necrosis of the mitral valve is the term used to describe the liquefaction of calcium present in its fibrous ring and the consequent formation of a pseudotumor with a thick, pasty content within. Although rare, this degenerative process has been widely described in the context of the mitral valve; however, it is little known in the context of constrictive pericarditis. We describe a series of seven cases that presented with constrictive pericarditis associated with caseous necrosis. Of the seven patients, six were male, with a mean age of 42&#177;14 years, all in functional class III/IV, with clinical signs related to restrictive syndrome. Chest tomography showed intense pericardial calcification with caseous necrosis, confirmed by pericardiectomy.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <p>
          <fig id="f01001">
            <label>Central Illustration:</label>
            <caption>
              <title>Constrictive Pericarditis with Caseous Necrosis: A Rare and Underrecognized Presentation</title>
            </caption>
            <attrib>Chest CT scans demonstrating calcific constrictive pericarditis with caseous necrosis. Yellow arrows highlight areas of caseous necrosis.</attrib>
            <graphic xlink:href="1678-4170-abc-122-10-e20250163-50163-gf01-en.tif"/></fig>
        </p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Constrictive Pericarditis</kwd>
        <kwd>Pericardium</kwd>
        <kwd>Heart Failure</kwd>
      </kwd-group>
      <funding-group>
        <funding-statement> There were no external funding sources for this study.</funding-statement>
      </funding-group>
    </front-stub>
    <body>
      <sec sec-type="intro">
        <title>Introduction</title>
        <p>Mitral annular calcification (MAC) is defined as a chronic degeneration of the fibrous annulus of the valve,<sup><xref ref-type="bibr" rid="B1">1</xref></sup> with caseous necrosis of the mitral annulus (CNVM), in turn, being a rare variant of this condition, in which liquefaction of the calcified content of this structure occurs.<sup><xref ref-type="bibr" rid="B2">2</xref></sup> Caseous necrosis, already widely described in the mitral valve, is rare and little recognized in the context of calcific constrictive pericarditis.</p>
        <p>We describe a series of cases demonstrating this unusual association between constrictive pericarditis (CP) and caseous necrosis (CN).</p>
      </sec>
      <sec sec-type="cases">
        <title>Case Report</title>
        <p>We describe seven patients with CP associated with CN, in an observational and retrospective manner, in a single center, a reference center for cardiomyopathies in Brazil. Among them, six were male, with a mean age of 42&#177;14 years. The presence of comorbidities was uncommon, observed in four of them, the most common being hypothyroidism and smoking (<xref ref-type="table" rid="t1001">Table 1</xref>).</p>
        <p>
          <table-wrap id="t1001">
            <label>Table 1</label>
            <caption>
              <title>&#8211; Baseline clinical, echocardiographic, laboratory, and anatomopathological characteristics</title>
            </caption>
            <table frame="hsides" rules="groups">
              <colgroup>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
                <col/>
              </colgroup>
              <thead>
                <tr>
                  <th>Patient</th>
                  <th>Sex/Age</th>
                  <th>PH</th>
                  <th>FC (NYHA) Pre Cx</th>
                  <th>Onset of complaint (months)</th>
                  <th>TTE Pre Cx</th>
                  <th>LVEF After Cx</th>
                  <th>AF</th>
                  <th align="left">Pericardial Biopsy</th>
                  <th>CRP (mg/dL)</th>
                  <th>NT-pro BNP (pg/mL)</th>
                  <th>FC (NYHA) After Cx</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center">P1</td>
                  <td align="center">M 62 years old</td>
                  <td align="center">Hypotonic, Obesity, Hypertension, CKD</td>
                  <td align="center">III</td>
                  <td align="center">2</td>
                  <td align="center">LVEF: 66%; LA: 50 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>; PSAP: absent; AR+/SB+</td>
                  <td align="center">59%</td>
                  <td align="center">Yes</td>
                  <td>Chronic pericarditis, fibrosis, and calcification. No malignancy or granuloma.</td>
                  <td align="center">2.0</td>
                  <td align="center">2350</td>
                  <td align="center">II</td>
                </tr>
                <tr>
                  <td align="center">P2</td>
                  <td align="center">M 35 years old</td>
                  <td align="center">Absent</td>
                  <td align="center">III</td>
                  <td align="center">2</td>
                  <td align="center">LVEF: 58%; LA: 26 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>; PSAP: absent; AR+/SB+</td>
                  <td align="center">61%</td>
                  <td align="center">No</td>
                  <td>Chronic pericarditis, fibrosis, and calcification. No malignancy or granuloma.</td>
                  <td align="center">1.9</td>
                  <td align="center">115</td>
                  <td align="center">I</td>
                </tr>
                <tr>
                  <td align="center">P3</td>
                  <td align="center">M 38 years old</td>
                  <td align="center">Smoking</td>
                  <td align="center">IV</td>
                  <td align="center">24</td>
                  <td align="center">LVEF: 58%; LA: 61 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>; PSAP: 39 mmHg; RV dysfunction; AR+/SB+</td>
                  <td align="center">60%</td>
                  <td align="center">No</td>
                  <td>Chronic pericarditis, fibrosis, and calcification. No malignancy or granuloma.</td>
                  <td align="center">0.5</td>
                  <td align="center">1329</td>
                  <td align="center">III</td>
                </tr>
                <tr>
                  <td align="center">P4</td>
                  <td align="center">F 60 years old</td>
                  <td align="center">Hypotonic, DLP, SAH</td>
                  <td align="center">III</td>
                  <td align="center">24</td>
                  <td align="center">LVEF: 62%; LA: 50 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>; PSAP: 35 mmHg; AR+/SB+</td>
                  <td align="center">62%</td>
                  <td align="center">No</td>
                  <td>Chronic pericarditis, fibrosis, and calcification. No malignancy or granuloma.</td>
                  <td align="center">0.5</td>
                  <td align="center">1500</td>
                  <td align="center">I</td>
                </tr>
                <tr>
                  <td align="center">P5</td>
                  <td align="center">M 40 years old</td>
                  <td align="center">Absent</td>
                  <td align="center">III</td>
                  <td align="center">12</td>
                  <td align="center">LVEF: 46%; LA: 43 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>; PSAP: 34 mmHg; RV dysfunction; AR+/SB+</td>
                  <td align="center">47%</td>
                  <td align="center">No</td>
                  <td>Chronic pericarditis, fibrosis, and calcification. No malignancy or granuloma</td>
                  <td align="center">0.9</td>
                  <td align="center">135</td>
                  <td align="center">II</td>
                </tr>
                <tr>
                  <td align="center">P6</td>
                  <td align="center">M 39 years old</td>
                  <td align="center">Hypotonic, CKD</td>
                  <td align="center">III</td>
                  <td align="center">24</td>
                  <td align="center">LVEF: 24%; LA: 65 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>; PSAP: 40 mmHg; RV dysfunction; AR+/SB+</td>
                  <td align="center">50%</td>
                  <td align="center">Yes</td>
                  <td>Chronic pericarditis, fibrosis and calcification, myxoid degeneration. No malignancy or granuloma.</td>
                  <td align="center">0.5</td>
                  <td align="center">1650</td>
                  <td align="center">I</td>
                </tr>
                <tr>
                  <td align="center">P7</td>
                  <td align="center">M 22 years old</td>
                  <td align="center">Absent</td>
                  <td align="center">II</td>
                  <td align="center">6</td>
                  <td align="center">LVEF: 65%; LA: 46 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>; PSAP: NA; AR+/SB+</td>
                  <td align="center">65%</td>
                  <td align="center">No</td>
                  <td>Chronic pericarditis, fibrosis, and calcification. No malignancy or granuloma.</td>
                  <td align="center">1.8</td>
                  <td align="center">IN</td>
                  <td align="center">I</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="TFN1001">
                <p>*&gt;3 months after surgery. PH: personal history; AR: annulus reversion; LA: left atrial volume; FC: functional class; Cx: surgery; DLP: dyslipidemia; CKD: chronic kidney disease; TTE: transthoracic echocardiogram; AF: atrial fibrillation; LVEF: left ventricular ejection fraction; SAH: systemic arterial hypertension; HypoT: hypothyroidism; HF: heart failure; CRP: C-reactive protein; PASP: pulmonary artery systolic pressure; NA: not assessed; NT-pro BNP: N-terminal pro BNP; NYHA: New York Heart Association; SB: septal bounce; RV: right ventricle.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </p>
        <p>Restrictive syndrome was the unanimous initial manifestation, expressed by progressive dyspnea, NYHA functional class III/IV, with predominant signs of right-sided heart failure (HF). Lower limb edema, ascites, pleural effusion, hepatomegaly, jugular distension, and hepatojugular reflux were present in all cases. No Kussmaul sign or pulsus paradoxus was reported in any of the patients. The mean time between symptom onset and hospital admission was at least 2 months (mean 13.4&#177;10.4 months), indicating a prolonged and progressive clinical picture.</p>
        <p>No significant changes were observed in laboratory tests, including leukocyte count and C-reactive protein (CRP) (1.15&#177;0.7 mg/dL). The mean NT-proBNP was 1179&#177;887 pg/mL.</p>
        <p>The transthoracic echocardiogram (TTE) confirmed the diagnosis of constrictive pericarditis, with typical findings of thickened, calcified pericardium, in addition to signs of ventricular interdependence. The left ventricular ejection fraction (LVEF) was reduced (less than 40%) in only one patient, with a mean of 54 &#177; 14.8%; however, in 42% of cases, there was right ventricle (RV) dysfunction. Other findings were left atrial enlargement (85%), with a mean volume of 48 &#177; 12 mL/m<xref ref-type="bibr" rid="B2"><sup>2</sup></xref> and pulmonary hypertension (57%). Heterogeneous hyperechoic images were observed, adhering to the pericardium, causing restriction of the chambers, especially the RV.</p>
        <p>A chest radiograph demonstrated radiopacity surrounding the cardiac silhouette. A chest computed tomography (CT) scan (<xref ref-type="fig" rid="f02001">Figure 1</xref>) confirmed pericardial thickening with significant hyperdensity, associated with &#8220;pseudotumors&#8221; with irregular contours and heterogeneous, more hypodense contents within them, causing bulging of the cardiac silhouette.</p>
        <p>
          <fig id="f02001">
            <label>Figure 1</label>
            <caption>
              <title>&#8211; Chest CT scans demonstrating calcific constrictive pericarditis with caseous necrosis. Chest CT scans showing thickened, calcified pericardium associated with irregularly contoured pseudotumors containing heterogeneous, hypodense contents (yellow arrows). &#8220;Patient 7A&#8221; and &#8220;Patient 7B&#8221; refer to the same patient, before and after pericardiectomy, respectively.</title>
            </caption>
            <graphic xlink:href="1678-4170-abc-122-10-e20250163-50163-gf02-en.tif"/></fig>
        </p>
        <p>During pericardiectomy, performed in all patients, the pericardium was found to be thickened, rigid, calcified, and adherent to adjacent structures. A moderate to large amount of a whitish, pasty substance resembling toothpaste was observed, originating from the &#8220;pseudotumors&#8221; present in the pericardium, known as CN or &#8220;caseum.&#8221; Recovery of ventricular function was evident after the procedure.</p>
        <p>In the late postoperative period, all patients showed significant improvement in symptoms, most progressing to NYHA functional class I-II, mainly after 3 months of surgery. The reduced LVEF, observed in a single patient, normalized 24 hours after surgery (24% to 50%). All patients remained mildly symptomatic during the mean follow-up of 2.7 years.</p>
        <p>Patients were evaluated for the etiology of pericarditis, including tuberculosis (TB), through anatomical pathology of the pericardium, which revealed no granulomas or malignancy in any of the patients. Bacilloscopy and culture for mycobacteria were negative in the samples, and there were no previous or subsequent clinical manifestations (fever, cough, weight loss, and night sweats) suggestive of active infectious diseases, such as TB.</p>
      </sec>
      <sec sec-type="discussion">
        <title>Discussion</title>
        <p>We describe seven cases of the rare and little recognized association of CN with constrictive pericarditis, whose description is scarce in the literature, reported in only one publication.<sup><xref ref-type="bibr" rid="B3">3</xref></sup></p>
        <p>However, the description of this degenerative process is already definitively consolidated concerning the mitral annulus.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref></sup> MAC occurs in 8 to 15% of the general population,<sup><xref ref-type="bibr" rid="B6">6</xref></sup> while CNVM, which is rarer, has a prevalence that is still unknown and underestimated, occurring at around 0.06-0.07%,<sup><xref ref-type="bibr" rid="B1">1</xref></sup> and is more prevalent in women, the elderly, hypertensive patients, chronic kidney patients, and those with alterations in calcium metabolism.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref></sup> It is usually asymptomatic, and multimodality imaging is essential for diagnosis.<sup><xref ref-type="bibr" rid="B2">2</xref></sup></p>
        <p>In this study, unlike the already widely recognized CN confined to the mitral valve, we describe its occurrence in calcific constrictive pericarditis. CP is characterized by inflammation of the pericardium that, in most cases, leads to fibrosis, with or without calcification, loss of elasticity, and ventricular diastolic dysfunction.<sup><xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B9">9</xref></sup> In fact, it can occur after any pericardial pathological process, the risk of progression to CP depending on the etiology: low (&lt;1%) in viral/idiopathic pericarditis, intermediate (2-5%) in neoplastic/autoimmune causes, and high (20-30%) in bacterial etiologies. Records from developed countries show that the main causes include cardiac surgery (11-37%), radiotherapy (9-31%), and viral or idiopathic etiologies (42-49%). TB, although a rare cause of pericarditis in these countries (&lt;4%), is still considered a classic etiology in less developed regions (50-70%), progressing, even with appropriate treatment, to CP in 17-40% of cases.<sup><xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B12">12</xref></sup> Regardless of the etiology, thickening and loss of elasticity of the pericardium lead to a state of ventricular interdependence, as well as a reduction in pericardial compliance, with a consequent reduction in the filling of the cardiac chambers and venous return (reflecting in signs and symptoms of restrictive syndrome, especially on the right, as presented by the reported patients).<sup><xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B12">12</xref></sup> Signs and symptoms of right-sided HF may be found in other differential diagnoses, such as restrictive cardiomyopathy,<sup><xref ref-type="bibr" rid="B8">8</xref></sup> but the evident echocardiographic findings of the seven patients related to ventricular interdependence, septal bounce, and annulus reversion, associated with evident pericardial disease, brought the diagnostic confirmation of constrictive pericarditis.</p>
        <p>In CP, the pericardium is thickened in 80% of cases<sup><xref ref-type="bibr" rid="B9">9</xref></sup> and calcified in 11 to 70% of cases, especially in cases of idiopathic CP, related to radiation or TB.<sup><xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref></sup> In the case series, the pericardium was thickened and calcified in all patients. Furthermore, the presence of structures consistent with &#8220;pseudotumors&#8221; in the pericardium was observed on imaging exams, the contents of which consisted of &#8220;caseum,&#8221; confirmed surgically, constituting CN.</p>
        <p>The pathophysiological mechanism of CN is not fully understood. The hypothesis raised in CNVM is based on the liquefaction of calcified material in the mitral annulus. Hypercholesterolemia and lipid-laden macrophages could lead to the formation of a cavity with a pasty material, similar to the appearance of &#8220;toothpaste,&#8221; composed of fatty acids, cholesterol, and calcium.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B14">14</xref></sup> We believe that, in cases of calcified CP, a similar pathophysiological mechanism is involved, due to the intense calcification shared in these scenarios.</p>
        <p>The chronic nature of the condition can be inferred by the long duration of symptoms associated with low systemic inflammation, reflected by reduced CRP levels.</p>
        <p>Natriuretic peptide levels were not correlated with symptom severity, probably due to the restriction of dilation of the cardiac chambers by pericarditis, as previously described in other publications in the context of CP.<sup><xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref></sup> A very significant clinical improvement was observed after pericardiectomy, with 85% of patients remaining in NYHA&#8804;II, associated with the absence of deaths occurring in the periprocedure (literature reports mortality around 6-12%<sup><xref ref-type="bibr" rid="B10">10</xref></sup>), which reaffirms the growing indication (increase in the performance of pericardiectomy from 2% to 34% in CP) and the benefit of this procedure, even in the face of intense calcification and CN.<sup><xref ref-type="bibr" rid="B12">12</xref></sup></p>
        <p>Regarding the etiology, it was considered idiopathic in all cases, with TB and malignancy, as well as other treatable causes, being excluded through laboratory evaluation, clinical history, and analysis of the biopsy material, which confirmed calcification, fibrosis, and nonspecific inflammation. These findings corroborate the possibility that CP can occur as a consequence of any pericardial injury.<sup><xref ref-type="bibr" rid="B9">9</xref></sup> and reflects other case series of calcified CP, where the idiopathic cause was the most prevalent.<sup><xref ref-type="bibr" rid="B15">15</xref></sup> It should be noted that, although TB is an important cause of CP in underdeveloped countries (and therefore essential for screening), the finding of CN in CP is not directly related to this etiology or even to its typical caseous granulomas. Although there is a similarity in nomenclature, the CN in question is secondary to the liquefaction of calcified material and is not a process exclusive to TB activity.<sup><xref ref-type="bibr" rid="B1">1</xref></sup></p>
        <p>We conclude that CN may occur in cases of intense pericardial calcification and that its occurrence does not imply a change in therapeutic strategy or prognosis. A deeper understanding of this condition requires further studies; however, the pioneering nature of this case series can contribute to further discussion and research.</p>
      </sec>
    </body>
    <back>
      <fn-group>
        <fn fn-type="other">
          <label>Study association:</label>
          <p> This study is not associated with any thesis or dissertation work.</p>
        </fn>
        <fn fn-type="other">
          <label>Ethics approval and consent to participate:</label>
          <p> This study was approved by the Ethics Committee of the Instituto Dante Pazzanese de Cardiologia under the protocol number CAAE: 85779125.3.0000.5462, protocol 7.405.668. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013. Informed consent was obtained from all participants included in the study.</p>
        </fn>
        <fn fn-type="other">
          <label>Use of Artificial Intelligence:</label>
          <p> The authors did not use any artificial intelligence tools in the development of this work.</p>
        </fn>
        <fn fn-type="data-availability" specific-use="data-in-article">
          <label>Data Availability Statement: </label>
          <p>The underlying content of the research text is contained within the manuscript.</p>
        </fn>
        <fn fn-type="financial-disclosure">
          <label>Sources of funding:</label>
          <p> There were no external funding sources for this study.</p>
        </fn>
      </fn-group>
    </back>
  </sub-article>
</article>
